GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $300,000 | -7.7% | 7,967 | +0.1% | 0.08% | -19.4% |
| Q2 2020 | $325,000 | +4.8% | 7,963 | -2.6% | 0.10% | -16.3% |
| Q1 2020 | $310,000 | -20.5% | 8,174 | -1.4% | 0.12% | -6.8% |
| Q4 2019 | $390,000 | +3.4% | 8,291 | -1.1% | 0.13% | +0.8% |
| Q3 2019 | $377,000 | -29.7% | 8,382 | -35.3% | 0.13% | -49.0% |
| Q2 2019 | $536,000 | -47.5% | 12,947 | -47.0% | 0.26% | -48.8% |
| Q1 2019 | $1,021,000 | +10.4% | 24,426 | +0.9% | 0.50% | -11.6% |
| Q4 2018 | $925,000 | – | 24,211 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |